Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam.

Trial Profile

Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2012

At a glance

  • Drugs Piperacillin/tazobactam (Primary) ; Vancomycin
  • Indications Bacterial infections; Febrile neutropenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top